Wednesday, July 8, 2026

biotech · Colorectal Cancer · Psoriatic Arthritis, Rheumatoid Arthritis · CRDF

Cardiff Oncology

Cardiff Oncology clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

11055 Flintkote Avenue, San Diego, California 92121, US HQ
1999 Founded
51 Employees
Public company Type
CRDF · NYSE Ticker
Company details
Status
Public
HQ
11055 Flintkote Avenue, San Diego, California 92121, US
Founded
1999
Employees
51
Programs
58
Drugs
62
Patents
69
Intelligence · Clinical Programs

Cardiff Oncology projects

4 ClinicalTrials.gov programs sponsored by Cardiff Oncology.

Cardiff Oncology has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. C19-A3 GNP

    Cardiff Oncology

    Type 1 Diabetes

    phase 1 small molecule completed

    1 trial
  2. Cobimetinib

    Cardiff Oncology

    Locally Advanced Pancreatic Ductal Adenocarcinoma

    phase 1 small molecule active

    1 trial
  3. Pembrolizumab

    Cardiff Oncology

    Anal Cancer Stage III A

    phase 1 small molecule active

    1 trial
  4. questionnaires

    Cardiff Oncology

    Anxiety

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does Cardiff Oncology have?

4 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.